These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33608409)

  • 1. Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species.
    van Groen BD; Nicolaï J; Kuik AC; Van Cruchten S; van Peer E; Smits A; Schmidt S; de Wildt SN; Allegaert K; De Schaepdrijver L; Annaert P; Badée J
    Pharmacol Rev; 2021 Apr; 73(2):597-678. PubMed ID: 33608409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.
    Shi S; Li Y
    Curr Drug Metab; 2014; 15(10):915-41. PubMed ID: 25828591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics.
    Kiss M; Mbasu R; Nicolaï J; Barnouin K; Kotian A; Mooij MG; Kist N; Wijnen RMH; Ungell AL; Cutler P; Russel FGM; de Wildt SN
    Drug Metab Dispos; 2021 Dec; 49(12):1038-1046. PubMed ID: 34548392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of drug-metabolizing enzymes by local and systemic liver injuries.
    Guo Y; Hu B; Xie Y; Billiar TR; Sperry JL; Huang M; Xie W
    Expert Opin Drug Metab Toxicol; 2016; 12(3):245-51. PubMed ID: 26751558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
    Rushmore TH; Kong AN
    Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of Hepatic Drug Transporters and Relevance to Drugs Used in Pediatrics.
    Elmorsi Y; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2016 Jul; 44(7):992-8. PubMed ID: 26712821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
    Xu C; Li CY; Kong AN
    Arch Pharm Res; 2005 Mar; 28(3):249-68. PubMed ID: 15832810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug disposition in pathophysiological conditions.
    Gandhi A; Moorthy B; Ghose R
    Curr Drug Metab; 2012 Nov; 13(9):1327-44. PubMed ID: 22746301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating Ontogeny in Physiologically Based Pharmacokinetic Modeling to Improve Pediatric Drug Development: What We Know About Developmental Changes in Membrane Transporters.
    Cheung KWK; van Groen BD; Burckart GJ; Zhang L; de Wildt SN; Huang SM
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1(Suppl 1):S56-S69. PubMed ID: 31502692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte model.
    Khatri R; Fallon JK; Rementer RJB; Kulick NT; Lee CR; Smith PC
    J Pharmacol Toxicol Methods; 2019; 98():106590. PubMed ID: 31158457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.
    Naji-Talakar S; Sharma S; Martin LA; Barnhart D; Prasad B
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):273-289. PubMed ID: 33256492
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of microRNAs in the regulation of drug metabolism and disposition.
    Yu AM
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1513-28. PubMed ID: 19785514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species.
    Basit A; Fan PW; Khojasteh SC; Murray BP; Smith BJ; Heyward S; Prasad B
    Drug Metab Dispos; 2022 Mar; 50(3):197-203. PubMed ID: 34969659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Liver Disease on Hepatic Transporter Expression and Function.
    Thakkar N; Slizgi JR; Brouwer KLR
    J Pharm Sci; 2017 Sep; 106(9):2282-2294. PubMed ID: 28465155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of hepatic enzyme activities of drug metabolizing enzymes-phenotyping and genotyping].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):63-76. PubMed ID: 10859937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication.
    Momper JD; Nigam SK
    Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):561-570. PubMed ID: 29746174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.
    Nigam SK; Bush KT; Bhatnagar V; Poloyac SM; Momper JD
    Clin Pharmacol Ther; 2020 Jul; 108(1):40-53. PubMed ID: 32119114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and Opportunities for Increasing the Knowledge Base Related to Drug Biotransformation and Pharmacokinetics during Growth and Development.
    Leeder JS; Meibohm B
    Drug Metab Dispos; 2016 Jul; 44(7):916-23. PubMed ID: 27302933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children.
    Hines RN
    Int J Pharm; 2013 Aug; 452(1-2):3-7. PubMed ID: 22766445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small interfering RNA in drug metabolism and transport.
    Yu AM
    Curr Drug Metab; 2007 Oct; 8(7):700-8. PubMed ID: 17979658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.